Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006695	-toxonho	— (—)	636	1241	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AD Calcineurin inhibitors

231

57.78

307.65

3.4

1.1

—

Transplanted organ and tissue status

244

86.18

307.65

3.3

1.0

—

L04AA Selective immunosuppressants

234

26.85

307.65

3.1

1.2

—

ILD medications: immunosuppressive drugs

337

152

20.23

307.65

2.7

1.1

—

ILD, hospital admission 2, with pulmonary infections

141

85.59

267.07

2.9

1.1

—

Other respiratory diseases principally affecting the interstitium

175

29.77

264.49

2.9

1.7

—

Other interstitial pulmonary diseases

165

35.19

262.21

2.9

1.6

—

ILD, hospital admissions

165

34.49

260.69

2.9

1.6

—

Interstitial lung disease endpoints

165

34.47

260.67

2.9

1.6

—

Interstitial lung disease

165

34.47

260.67

2.9

1.6

—

ILD, hospital admissions 1, main diag only

152

38.02

246.63

3.0

1.7

—

ILD medications: prednisolone, methylprednisolone, prednisone

358

173

11.55

243.71

2.4

1.1

—

ILD, hospital admissions 3, with pneumonia sepsis

123

97.75

236.73

2.9

1.3

—

Oral corticosteroids

351

226

9.14

216.27

2.5

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

159

71.55

214.17

2.9

1.3

—

First line medication for Crohn's disease

318

154

11.15

208.04

2.2

1.1

—

ILD medications

330

174

10.26

206.64

2.2

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

329

264

8.17

199.97

2.4

1.5

—

Inflammatory bowel disease treatment related agents

345

230

8.35

193.88

2.4

1.2

—

All pneumoniae

327

273

7.81

191.77

2.4

1.5

—

Idiopathic pulmonary fibrosis

109

51.23

189.39

3.4

1.6

—

Pneumonia, organism unspecified

295

241

8.42

188.35

2.4

1.6

—

Influenza and pneumonia

330

264

7.74

186.91

2.3

1.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

288

186

9.08

176.55

2.4

1.5

—

288

186

9.08

176.55

2.4

1.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

308

291

7.07

169.45

2.4

1.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

293

257

7.23

159.66

2.7

1.1

—

Liquid cancers

160

121

12.63

159.03

1.5

2.3

—

Fever of other and unknown origin

213

211

8.79

158.55

1.9

1.8

—

Primary_lymphoid and hematopoietic malignant neoplasms

142

104

13.81

153.41

1.5

2.2

—

Liquid cancers, including Hilmo

167

141

10.52

142.34

1.5

2.2

—

Abnormal findings on diagnostic imaging of lung

175

210

7.94

125.47

2.0

2.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

216

298

6.33

122.21

1.9

2.1

—

Bacterial pneumonia (organism specified)

160

180

8.09

114.18

2.4

1.6

—

Implicit viral Sepsis

107

13.17

112.54

2.6

1.8

—

Viral Sepsis

107

13.17

112.54

2.6

1.8

—

Bacterial infection, other or unspecified

182

218

7.08

112.41

1.8

2.1

—

ILD-related respiratory insufficiency

59.15

110.35

3.6

1.0

—

Bacterial infection, other or unspecified, including avohilmo

188

243

6.36

104.26

1.8

2.1

—

Other bacterial diseases

251

325

5.13

102.67

2.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

254

350

4.90

99.81

2.0

1.9

—

Non-Hodgkin lymphoma, all, including Hilmo

18.01

99.20

1.5

2.2

—

Early onset COPD, excluding more controls

23.03

97.96

3.4

1.1

—

ILD medications: azathioprine

21.38

96.41

2.0

1.1

—

Implicit viral Sepsis, including avohilmo

118

136

8.71

93.47

2.4

1.8

—

Other diseases of pleura

155

201

6.73

92.88

2.8

1.6

—

Bacterial pneumoniae

121

120

8.89

91.64

2.6

1.5

—

Bacterial pneumonia, not elsewhere classified

115

111

9.14

88.88

2.7

1.5

—

Covid-19 confirmed case

128

174

7.39

88.43

2.9

1.5

—

Other diseases of the respiratory system

11.37

84.50

3.3

1.6

—

Other respiratory disorders and diseases

11.37

84.50

3.3

1.6

—

Azathioprine

15.46

82.81

2.0

1.2

—

Dialysis, with operation codes

14.07

81.81

2.3

1.9

—

COPD-related respiratory insufficiency

16.79

81.48

3.6

1.4

—

Protozoal diseases, including avohilmo

33.25

79.11

1.9

2.1

—

Provisional assignment of new diseases of uncertain etiology

155

288

5.36

77.86

2.7

1.6

—

Codes for special purposes

155

289

5.34

77.55

2.7

1.6

—

Protozoal diseases

32.64

77.10

1.9

2.1

—

Infections, IBD-co-morbidities

18.41

77.08

2.4

1.2

—

Pneumocystosis

44.68

76.86

1.8

1.4

—

Pneumocystosis, including avohilmo

44.68

76.86

1.8

1.4

—

Other bacterial diseases, including avohilmo

230

330

4.36

76.82

1.9

2.0

—

Fungal Sepsis

33.57

76.41

2.2

—

Bacterial Sepsis

142

195

6.04

75.39

2.2

1.9

—

Implicit fungal Sepsis, including avohilmo

23.87

75.31

2.1

1.8

—

Viral pneumonia

20.53

74.99

2.4

1.2

—

Other diseases of blood and blood-forming organs, wide

104

8.92

74.26

1.9

—

Inflammatory diseases of the central nervous system

16.01

73.56

1.6

2.1

—

Implicit fungal Sepsis

32.24

72.37

2.3

2.2

—

Second line medication for Crohn's disease

167

357

4.69

72.15

2.1

2.0

—

Non-follicular lymphoma

16.91

72.07

1.4

2.0

—

Implicit bacterial Sepsis

128

175

6.30

71.79

2.3

1.8

—

Any death

174

246

4.97

70.52

1.8

2.3

—

L04AX Other immunosuppressants

162

346

4.70

70.14

2.1

2.0

—

Viral infections characterized by skin and mucous membrane lesions

132

240

5.52

68.74

2.3

1.9

—

Nephropathy related operations

12.04

68.60

2.3

2.0

—

Implicit Sepsis

186

307

4.47

68.41

2.4

1.8

—

Dental caries

100

128

7.41

67.69

2.6

1.9

—

Implicit bacterial Sepsis, including avohilmo

132

190

5.80

67.53

2.3

1.9

—

Cytomegaloviral disease

34.64

67.37

2.4

2.3

—

Cytomegaloviral disease, including avohilmo

34.62

67.36

2.4

2.3

—

COPD/asthma/ILD related infections

188

186

5.07

67.02

2.1

1.5

—

COPD/asthma related infections

188

186

5.07

67.02

2.1

1.5

—

All influenza

10.18

66.01

2.4

1.4

—

Cytomegalovirus infection, IBD co-morbidity

32.23

65.91

2.4

2.2

—

Persons encountering health services for specific procedures and health care

230

349

3.90

65.51

2.2

1.8

—

Certain disorders involving the immune mechanism

8.88

65.17

1.9

—

Other medical care

128

197

5.47

61.95

2.0

1.7

—

Caries of dentine

119

7.34

60.94

2.7

2.0

—

Implicit Sepsis, including avohilmo

187

329

4.07

60.56

2.4

1.8

—

Other viral diseases

151

6.50

60.24

2.3

1.9

—

COPD (mode)

12.59

58.63

3.3

1.0

—

Chronic kidney disease

137

6.63

58.10

2.1

1.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

187

329

3.94

57.58

2.4

1.8

—

Mycoses

153

6.31

57.41

2.6

1.8

—

Asthma

127

104

6.31

56.02

2.6

1.2

—

217

292

3.77

55.84

2.3

1.5

—

Certain infectious and parasitic diseases

159

162

4.92

55.15

2.1

1.4

—

Diagnoses used for exclusion with ILD

113

7.21

54.89

2.1

1.9

—

Oxycodone

110

171

5.52

54.18

1.8

1.9

—

Asthma, excluding more controls

124

102

6.25

54.17

2.6

1.2

—

Acute bronchitis

108

201

5.29

53.44

3.1

1.6

—

Other acute lower respiratory infections

136

300

4.33

52.56

2.9

1.7

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

195

439

3.46

52.08

2.1

1.9

—

Renal failure

126

229

4.70

51.92

2.2

1.9

—

Bronchitis

216

383

3.39

51.22

2.5

1.6

—

Anaemias

12.67

51.19

2.2

1.0

—

General symptoms and signs

191

248

3.86

50.48

2.1

1.7

—

Asthma (only as main-diagnosis)

112

104

6.03

49.68

2.6

1.2

—

Respiratory insufficiency

70.64

49.08

3.5

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

182

342

3.60

49.08

2.5

1.8

—

Other viral diseases, including avohilmo

104

205

5.04

48.96

2.3

2.0

—

Asthma (only as main-diagnosis), excluding more controls

111

102

6.03

48.94

2.6

1.2

—

Pulmonary heart disease, diseases of pulmonary circulation

162

5.64

48.63

2.5

1.7

—

Asthma-related pneumonia

101

199

5.08

48.04

2.9

1.6

—

Asthma, hospital admissions 3, pneumonia

101

199

5.08

48.04

2.9

1.6

—

Asthma-related pneumonia or sepsis

101

199

5.08

48.04

2.9

1.6

—

Immunodeficiencies

19.83

47.67

1.6

—

Septicaemia

102

182

5.12

47.57

1.8

2.0

—

Explicit Sepsis

107

200

4.89

47.26

1.8

1.7

—

Pneumonia due to other infectious organisms, not elsewhere classified

105.89

47.10

1.9

1.4

—

Explicit Sepsis, including avohilmo

108

203

4.84

47.06

1.8

1.7

—

Agranulocytosis

10.30

46.63

1.9

2.1

—

Early onset COPD

104

6.87

46.07

3.4

1.8

—

Other septicaemia

161

5.35

45.02

1.9

2.0

—

Other septicaemia, including avohilmo

164

5.28

44.84

1.9

2.0

—

Other pulmonary heart/vessel disease

18.33

44.76

3.5

1.9

—

Zoster [herpes zoster]

7.87

44.61

2.2

1.7

—

Emphysema

16.01

44.35

3.1

1.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

6.70

44.09

3.4

1.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

203

339

3.26

44.02

1.7

2.1

—

Diseases of oesophagus, stomach and duodenum

205

383

3.16

43.70

2.6

1.6

—

Renal tubulo-interstitial diseases

178

396

3.30

43.43

2.1

1.9

—

Autoimmune diseases excluding thyroid diseases

205

347

3.21

43.27

1.7

2.1

—

Failure and rejection of transplanted organs and tissues

85.97

42.65

3.2

2.2

—

Acute upper respiratory infections

194

363

3.21

42.47

2.1

1.8

—

Acute upper respiratory infections of multiple and unspecified sites

156

323

3.53

42.09

2.4

1.8

—

Acute sinusitis

120

270

4.05

42.02

2.3

1.7

—

Acute renal failure

7.03

41.83

2.3

2.1

—

GASTRO-related operations

111

105

5.31

41.61

2.0

1.3

—

Any gastric operation

111

105

5.31

41.61

2.0

1.3

—

Other pulmonary diagnosis

111

105

5.30

41.54

2.2

1.2

—

Heart failure, not strict

161

316

3.43

40.59

2.4

1.9

—

COPD differential diagnosis

108

105

5.16

39.40

2.1

1.2

—

ILD differential diagnosis

108

105

5.16

39.40

2.1

1.2

—

Asthma, unspecified (mode)

6.06

39.39

2.5

1.2

—

Asthma (mode)

104

105

5.21

39.20

2.2

1.2

—

Excluding asthma or asthma-COPD overlap

107

105

5.11

38.69

2.1

1.2

—

COPD, hospital admission 2, with asthma infections

126

5.42

38.37

3.3

1.7

—

All chronic kidney diseases

123

257

3.82

38.30

2.2

2.0

—

Zoster [herpes zoster], including avohilmo

110

269

3.96

38.03

2.1

1.8

—

Asthma, unspecified (mode), excluding more controls

5.98

37.80

2.5

1.2

—

All kidney diseases

184

415

2.97

37.03

2.1

1.9

—

Autoimmune diseases related-to ILD

141

352

3.35

36.73

1.7

—

Care involving use of rehabilitation procedures

121

300

3.63

36.38

2.3

1.9

—

Reimbursement for rheumatic diseases

120

334

3.58

36.25

1.7

1.9

—

Pain, not elsewhere classified

105

6.02

36.12

3.1

1.7

—

Malignant neoplasm, wide definition

155

269

3.36

36.11

2.0

2.3

—

Malignant neoplasm

153

266

3.37

35.95

1.8

2.3

—

Malignant neoplasm, including Hilmo

154

268

3.35

35.77

2.0

2.3

—

Secondary and unspecified malignant neoplasm of lymph nodes

13.19

35.70

1.2

2.1

—

Dyspnoea

170

409

3.00

35.61

2.4

1.8

—

Malignant neoplasm

152

266

3.35

35.39

1.8

2.3

—

Kidney transplant status

13.39

34.86

2.1

2.7

—

Care involving dialysis

13.32

34.83

1.5

1.7

—

Hard cardiovascular diseases

155

285

3.22

34.07

2.9

1.4

—

Tramadol

141

253

3.36

33.23

2.2

1.8

—

Secondary uncertain malignant neoplasm

9.12

32.10

1.2

2.3

—

All influenza (not pneumonia)

9.53

31.47

2.5

1.3

—

Asthma, hospital admission 2, infections

123

373

3.22

31.44

2.6

1.8

—

Asthma-related infections

123

373

3.22

31.44

2.6

1.8

—

Percutaneous Coronary Intervention

145

280

3.15

31.25

3.1

1.3

—

Lung diseases due to external agents

8.24

31.19

2.4

2.1

—

Abnormalities of breathing

151

278

3.11

31.18

2.2

1.7

—

Any reimbursement code in KELA

5.50

31.08

2.1

1.0

—

COPD

200

3.91

31.06

3.0

1.7

—

Examination and observation for other reasons

110

160

3.89

30.99

2.4

1.5

—

L01XE Protein kinase inhibitors

11.60

30.96

2.2

1.8

—

Other cataract

184

3.93

30.69

2.1

—

Viral warts

8.90

30.68

2.4

1.7

—

Coronary revascularization (ANGIO or CABG)

144

280

3.13

30.63

3.1

1.3

—

Emergency coronary revascularization (for ACS)

152

304

3.02

30.53

3.0

1.3

—

Enlarged lymph nodes

7.58

30.52

1.2

2.0

—

Coagulation defects, purpura and other haemorrhagic conditions

5.68

30.27

1.7

1.9

—

Diffuse large B-cell lymphoma

33.12

30.04

1.6

2.3

—

Diffuse large B-cell lymphoma, helper endpoint

33.12

30.04

1.6

2.3

—

Diffuse large B-cell lymphoma, including Hilmo

33.12

30.04

1.6

2.3

—

Other/unspecified cytomegaloviral diseases

36.30

29.91

2.4

1.4

—

Other metabolic disorders

7.02

29.21

2.8

1.7

—

COPD, hospital admissions 1, only main diagnosis

139

4.53

29.04

3.3

1.7

—

Drug-induced neutropenia

9.81

28.56

1.9

1.7

—

Ischemic heart diseases

145

290

2.98

28.37

3.0

1.3

—

Aplastic and other anaemias

250

3.52

27.81

2.2

1.9

—

Major coronary heart disease event

146

300

2.92

27.58

3.1

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

6.92

27.52

1.2

2.2

—

Intestinal infectious diseases

165

467

2.63

27.51

2.1

1.9

—

Continuous positive airway pressure

6.47

27.47

2.8

1.1

—

Non-Hodgkin lymphoma, all

35.63

27.47

1.3

2.4

—

Chronic lower respiratory diseases

199

418

2.51

27.40

2.6

1.7

—

Unspecified acute lower respiratory infection

6.50

27.22

3.1

1.2

—

Viral warts, including avohilmo

5.37

27.04

2.2

1.6

—

Pulmonary embolism

141

4.55

26.96

2.1

1.8

—

Certain infectious and parasitic diseases, including avohilmo

117

4.03

26.44

2.0

1.4

—

Any event in cancer register

150

312

2.81

26.42

1.9

2.2

—

Pleural effusion

7.86

26.36

2.5

1.5

—

Osteopathies and chondropathies

110

323

3.12

26.31

2.0

1.9

—

Osteoporosis

119

4.73

26.15

2.0

1.6

—

Other and unspecified anaemias

226

3.58

25.75

2.1

1.8

—

Other chronic obstructive pulmonary disease

192

3.67

25.70

3.1

1.6

—

Cough

195

3.79

25.63

2.2

1.8

—

Systemic connective tissue disorders

190

3.91

25.55

1.6

1.8

—

Pulmonary heart disease

148

4.34

25.39

2.1

1.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

128

409

2.80

25.18

2.0

1.9

—

Neoplasms

117

189

3.25

25.18

2.1

1.9

—

Other anaemias

229

3.52

25.12

2.1

1.8

—

6.34

24.76

3.5

1.8

—

273

3.31

24.58

2.6

1.8

—

Disorders of lens

123

257

2.97

24.36

2.3

2.1

—

Chorioretinal inflammation

29.87

24.17

1.4

2.5

—

Other disorders of fluid, electrolyte and acid-base balance

155

4.08

24.15

1.7

1.5

—

Dermatitis

115

394

2.86

24.07

2.1

1.9

—

Encephalitis

23.29

23.98

1.5

1.6

—

Other reaction to severe stress, and adjustment disorders

209

3.64

23.77

2.4

1.8

—

Drug-induced cataract

29.12

23.28

2.4

1.7

—

Other and unspecified dermatitis

102

343

2.98

23.13

1.9

—

Secondary right heart disease

18.78

23.07

3.6

1.5

—

Other disorders of skin and subcutaneous tissue

127

398

2.70

23.05

2.2

1.9

—

Herpesviral [herpes simplex] infections

6.90

22.88

1.9

1.7

—

Other encephalitis

23.49

22.67

1.5

1.6

—

COPD related to multimorbidity

181

3.60

22.65

3.2

1.9

—

Other heart diseases

138

3.73

22.38

2.1

1.3

—

Heart failure and antihypertensive medication

4.69

22.09

2.4

1.2

—

Headache

230

3.16

22.08

1.6

1.8

—

Immunodeficiency with predominantly antibody defects

29.79

21.94

1.4

1.7

—

DVT of lower extremities and pulmonary embolism

249

3.29

21.92

2.2

1.8

—

COPD, hospital admissions

222

3.27

21.84

3.1

1.8

—

Allergic asthma (mode)

7.01

21.73

2.4

1.1

—

Enterocolitis due to Clostridium difficile

7.73

21.66

1.9

1.8

—

Hypo-osmolality and hyponatraemia

5.43

21.66

1.6

—

Candidiasis

5.66

21.59

2.5

1.5

—

Seborrhoeic keratosis

125

4.33

21.46

2.3

1.9

—

Myeloid leukaemia

27.06

21.42

1.4

1.7

—

Gastro-oesophageal reflux disease

112

342

2.77

21.36

2.4

1.7

—

COPD, early/later onset

225

3.21

21.24

3.1

1.8

—

Venous thromboembolism

325

2.91

21.15

2.0

1.9

—

Presence of other functional implants

167

3.41

21.11

1.8

1.2

—

Diseases of the respiratory system

4.00

21.03

2.0

1.2

—

Thrombocytopenia, unspecified

8.50

21.01

1.6

2.0

—

Complications of medical and surgical care

124

434

2.57

20.82

2.0

—

Metabolic disorders

148

360

2.47

20.66

2.5

1.8

—

Purpura and other haemorrhagic conditions

5.70

20.66

1.5

1.9

—

Allergic asthma (mode), excluding more controls

6.58

20.52

2.4

1.1

—

Solid cancers, including Hilmo

123

264

2.72

20.51

2.0

2.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.51

20.45

3.0

2.1

—

Cardiovascular diseases (excluding rheumatic etc)

173

3.14

20.16

2.2

1.4

—

Solid cancers

120

259

2.72

20.08

1.8

2.3

—

Autoimmune diseases

163

348

2.38

20.06

1.7

2.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

19.08

19.98

1.6

—

Other bacterial intestinal infections

5.08

19.72

1.9

1.8

—

Oedema, not elsewhere classified

123

4.14

19.37

2.9

1.7

—

Viral infections of the central nervous system, including avohilmo

8.39

19.26

1.5

2.2

—

Rare circulating lymphoid malignancy, including Hilmo

46.82

19.24

1.4

2.0

—

Malaise and fatigue

171

3.36

19.08

1.9

1.8

—

Viral pneumonia (unknown virus, not influenza)

15.94

18.78

2.5

2.3

—

Intestinal infectious diseases, including avohilmo, including avohilmo

172

432

2.22

18.68

2.0

1.9

—

Disorders of eyelid, lacrimal system and orbit

137

423

2.37

18.65

2.0

—

Lymphoid leukaemia

14.27

18.57

1.4

2.0

—

Other viral diseases, not elsewhere classified

4.62

18.53

2.7

1.9

—

Bacterial intestinal infections, IBD co-morbidities

4.78

18.42

1.9

—

Other and unspecified polyneuropathies, also in other diseases

4.68

18.40

2.1

1.8

—

Malignant neoplasm of brain, including Hilmo

30.32

18.34

1.5

2.9

—

Pain in throat and chest

118

269

2.60

18.25

2.1

1.7

—

Abnormal findings on diagnostic imaging of central nervous system

17.71

18.24

1.3

2.1

—

Haemorrhage from respiratory passages

147

3.62

18.09

2.5

1.7

—

Iridocyclitis

121

4.06

17.95

1.2

2.0

—

Disorders of lacrimal system

242

3.05

17.80

2.0

1.8

—

Focal epilepsy, strict definition

101

4.37

17.71

1.7

1.8

—

Opioids

135

286

2.44

17.68

2.1

1.8

—

Other chronic obstructive pulmonary disease, including avohilmo

279

2.74

17.43

3.1

1.8

—

Sarcoidosis

5.10

17.38

2.1

2.0

—

Viral pneumonia (known virus, not influenza)

24.47

17.36

2.6

2.0

—

Candidiasis, including avohilmo

170

3.48

17.35

2.1

1.7

—

Symptoms and signs involving the skin and subcutaneous tissue

116

455

2.41

17.28

2.3

1.9

—

Mycoses, including avohilmo

144

491

2.23

17.25

2.2

1.9

—

Senile cataract

103

233

2.69

17.18

2.4

2.2

—

Polyneuropathies and other disorders of the peripheral nervous system

109

4.14

16.93

2.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

4.34

16.79

1.8

1.9

—

Aspergillosis

42.47

16.52

3.6

1.2

—

Aspergillosis, including avohilmo

42.39

16.52

3.6

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

149

435

2.20

16.51

2.0

1.9

—

Dermatitis and eczema

165

460

2.12

16.49

2.1

1.9

—

Asthma/COPD (KELA code 203)

140

417

2.24

16.47

2.6

1.7

—

Focal epilepsy

116

3.98

16.39

1.7

1.8

—

Disorders of sclera, cornea, iris and ciliary body

371

2.57

16.38

1.5

2.0

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

14.32

16.29

1.5

2.3

—

Complications of surgical and medical care, not elsewhere classified

149

457

2.18

16.29

2.0

1.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

130

3.30

16.16

2.0

1.3

—

Medical observation and evaluation for suspected diseases and conditions

162

2.87

16.15

2.1

1.5

—

Other skin changes

4.28

16.13

2.5

1.9

—

Non-invasive ventilation

4.10

15.99

2.5

1.2

—

Chronic sinusitis

279

2.80

15.93

2.4

1.8

—

Epilepsy

185

3.24

15.81

1.7

—

General examination and investigation of persons without complaint and reported diagnosis

162

2.86

15.72

2.5

1.5

—

Other disorders of lacrimal gland

208

3.08

15.56

1.9

1.7

—

Convulsions, not elsewhere classified

4.52

15.53

2.1

2.0

—

Cystic fibrosis with pulmonary manifestations

+∞

15.40

4.3

0.0

—

Persons encountering health services in other circumstances, wide

160

388

2.12

15.35

2.2

1.8

—

Glomerular diseases

4.18

15.26

1.4

1.9

—

Myeloproliferative diseases

7.01

15.25

1.3

1.8

—

Other bacterial intestinal infections, including avohilmo

114

3.87

15.15

1.9

1.8

—

Bleeding

128

402

2.23

15.12

2.2

2.0

—

Asthma (diagnoses ohter than nonallergic)

131

485

2.18

15.11

2.5

1.8

—

Heart failure,strict

220

2.70

14.91

2.1

2.0

—

Nausea and vomiting

130

3.61

14.86

1.7

1.6

—

Other necrotizing vasculopathies (FG)

12.50

14.85

1.6

2.0

—

Gastroduodenal ulcer

102

4.02

14.84

1.9

1.6

—

Used for control exclusion in common control thyroid runs

142

326

2.20

14.78

1.8

2.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

154

388

2.11

14.75

2.1

1.8

—

Hypertension, Pulmonary Arterial

+∞

14.69

4.6

0.0

—

Melanocytic naevi

175

3.21

14.56

2.6

1.8

—

Dermatophytosis

4.94

14.49

2.1

1.6

—

Other necrotizing vasculopathies

10.89

14.47

1.6

1.7

—

Pneumothorax

10.89

14.47

3.3

2.2

—

Other heart diseases, wide

132

364

2.20

14.45

2.1

1.8

—

Cardiovascular diseases

151

2.85

14.41

2.1

1.4

—

Glomerular disorders in diseases classified elsewhere

5.20

14.36

1.6

2.1

—

Non-allergic asthma (mode)

6.52

14.28

3.1

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

388

2.40

14.27

2.1

2.0

—

Cerebrovascular diseases (FINNGEN)

100

3.58

14.18

1.9

1.3

—

Cystic fibrosis with intestinal manifestations

+∞

14.15

4.5

0.0

—

Anterior Iridocyclitis

111

3.80

14.09

1.2

1.9

—

Carcinoma in situ of skin

6.70

14.02

4.0

1.8

—

Respiratory disorders in diseases classified elsewhere

30.99

13.96

2.2

1.3

—

Non-allergic asthma (mode), excluding more controls

6.34

13.91

3.1

1.1

—

ILD medications: nintedanib

+∞

13.70

3.9

0.0

—

Viral infections of the central nervous system

10.49

13.22

1.5

2.5

—

Diaphragmatic hernia

219

2.84

13.08

1.9

1.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

23.33

12.98

1.6

1.9

—

Malignant neoplasm of eye, brain and central nervous system

19.18

12.91

1.6

3.2

—

Other viral diseases, not elsewhere classified, including avohilmo

138

3.32

12.66

2.6

1.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.37

12.55

2.1

1.6

—

Chronic lymphocytic leukaemia

24.60

12.48

1.1

3.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

24.60

12.48

1.1

3.0

—

Chronic lymphocytic leukaemia, helper endpoint

24.60

12.48

1.1

3.0

—

Malignant neoplasm of brain

24.53

12.47

1.6

3.1

—

Symptoms and signs involving the circulatory and respiratory systems

121

278

2.18

12.46

2.1

1.7

—

Visual disturbances and blindness

335

2.42

12.46

1.6

1.9

—

Gastric ulcer

4.68

12.33

2.2

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

153

2.83

12.17

2.6

2.4

—

Extracorporeal dialysis

8.70

12.00

1.6

2.0

—

Hernia of abdominal wall, postoperative

5.97

11.99

1.7

1.4

—

Bronchiectasis

10.06

11.97

2.0

1.4

—

Asthma, hospital admissions , main diagnosis only

116

488

2.07

11.96

2.6

1.8

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.85

11.95

2.4

1.3

—

Disorders of optic nerve and visual pathways

5.37

11.81

1.9

1.7

—

Malignant neoplasm of skin, including Hilmo

178

2.64

11.72

2.5

2.4

—

Status epilepticus

16.54

11.67

1.4

1.7

—

Osteonecrosis

9.27

11.48

1.9

1.8

—

Undetermined asthma

10.02

11.46

1.9

1.1

—

Undetermined asthma, excluding more controls

10.02

11.46

1.9

1.1

—

Meningitis

10.59

11.26

1.4

2.8

—

Retinal vascular occlusion

5.54

11.16

1.7

1.8

—

Retinal vascular disorders

5.54

11.15

1.7

1.8

—

Visual disturbances

310

2.39

11.15

1.6

1.9

—

Covid-19 suspected case

3.70

11.09

2.4

1.3

—

Sulfasalazine

3.76

10.98

1.3

1.1

—

Cardiac arrhythmias

188

2.49

10.84

2.4

1.3

—

Atrial fibrillation and flutter

3.23

10.80

2.5

1.3

—

Heart failure and coronary heart disease

147

2.77

10.78

2.2

1.3

—

Acute and subacute iridocyclitis

104

3.47

10.68

1.2

1.9

—

Vocal cord dysfunction

5.07

10.65

1.6

1.2

—

Allergic bronchopulmonary aspergillosis (ABPA)

+∞

10.53

2.9

0.0

—

Other diseases of upper respiratory tract

144

395

1.90

10.51

1.9

—

Chronic iridocyclitis

9.21

10.50

1.2

2.6

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

7.87

10.47

2.2

1.9

—

Disorders of mineral metabolism

5.43

10.39

2.0

1.6

—

Erysipelas

246

2.42

10.39

1.7

2.1

—

Multiple myeloma, including Hilmo

16.13

10.35

1.8

2.4

—

Other infectious diseases, including avohilmo

5.14

10.30

1.4

2.1

—

Heart failure, strict

268

2.23

10.29

2.1

—

Polyarthropathies

106

332

2.05

10.11

1.6

2.1

—

Nutritional anaemias

273

2.38

10.06

2.0

1.7

—

All-cause Heart Failure

262

2.23

10.06

2.1

—

Preparatory care for dialysis

10.10

10.01

1.2

2.4

—

Diseases of the skin and subcutaneous tissue

117

292

2.01

9.94

2.5

1.5

—

Explicit bacterial Sepsis

5.14

9.82

1.5

1.9

—

Anxiety disorders, excluding more controls

116

378

1.96

9.80

2.3

1.9

—

Presence of cardiac and vascular implants and grafts

123

2.87

9.72

2.1

1.2

—

Other disorders involving the immune mechanism, not elsewhere classified

13.49

9.68

1.9

2.0

—

Unspecified kidney failure

7.36

9.67

2.6

2.1

—

Disorders of choroid and retina

112

400

1.96

9.65

1.5

2.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

162

2.38

9.62

2.3

1.5

—

Dysphagia

132

3.04

9.62

1.6

1.7

—

Chronic gastritis

127

3.08

9.59

3.0

1.6

—

Codeine

106

282

2.03

9.47

2.3

1.8

—

Other meningitis

17.84

9.43

1.2

1.3

—

Intracranial and intraspinal abscess and granuloma

22.26

9.40

2.0

1.3

—

Iron deficiency anaemia

237

2.44

9.37

2.1

1.8

—

Herpesviral [herpes simplex] infections, including avohilmo

129

3.03

9.35

1.8

1.6

—

Maternal care for known or suspected fetal abnormality and damage

3.53

9.34

1.4

1.6

—

Erysipelas, including avohilmo

286

2.15

9.27

1.7

2.1

—

Acute bronchiolitis

11.01

9.21

2.5

1.6

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

13.79

9.19

1.9

2.1

—

SLE (Finngen)

13.76

9.18

1.8

—

Non-ischemic cardiomyopathy

130

2.81

9.16

2.1

1.6

—

Factors influencing health status and contact with health services

4.10

9.13

2.5

1.1

—

Methotrexate

5.01

9.08

1.3

1.2

—

Retinal detachments and breaks

222

2.48

9.06

1.5

2.1

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

15.80

9.05

1.8

1.3

—

Explicit bacterial Sepsis, including avohilmo

4.78

9.05

1.6

2.0

—

Hypertensive diseases (excluding secondary)

138

2.53

9.02

2.3

1.3

—

Secondary hypertension

9.89

8.91

1.6

1.1

—

Neurotic, stress-related and somatoform disorders

121

449

1.86

8.89

2.2

1.9

—

Paroxysmal tachycardia

3.35

8.88

2.0

1.3

—

Gingival hyperplasia

10.77

8.79

2.2

2.0

—

Gastrointestinal diseases

136

2.43

8.78

2.2

1.3

—

Other gastritis (incl. Duodenitis)

3.27

8.73

2.5

1.4

—

Coronary atherosclerosis

230

2.17

8.68

2.5

1.3

—

Malignant neoplasm of skin

168

2.42

8.60

2.2

2.4

—

Wegener granulomatosis

16.58

8.58

1.8

1.5

—

Drug-induced osteoporosis with pathological fracture

16.57

8.58

2.4

1.4

—

Budesonide

4.56

8.58

1.9

1.1

—

Systemic lupus erythematosus

11.65

8.57

1.8

1.4

—

Disorders of calcium metabolism

8.23

8.56

2.1

1.3

—

Anxiety disorders

121

453

1.83

8.55

2.2

1.9

—

Other diseases of oesophagus

6.92

8.52

2.7

1.5

—

Infection due to other mycobacteria

20.35

8.49

2.9

1.2

—

Infection due to other mycobacteria, including avohilmo

20.32

8.49

2.9

1.2

—

Polycythaemia vera

20.16

8.47

1.4

3.3

—

Other pleural conditions

6.39

8.46

2.6

1.5

—

Ulcer of lower limb, not elsewhere classified

4.16

8.44

1.1

2.0

—

Non-rheumatic valve diseases

203

2.29

8.36

1.8

—

Bacterial, viral and other infectious agents, including avohilmo

4.46

8.36

2.2

—

Procreative management

167

2.52

8.34

2.4

1.9

—

Insulin, combination of fast acting with intermediate-acting or long-acting

384

2.01

8.32

2.4

2.0

—

STROKE

204

2.25

8.28

1.9

1.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3.17

8.25

1.0

2.5

—

Abnormalities of heart beat

167

2.62

8.24

2.2

1.6

—

Biological medication for rheuma

107

3.09

8.22

1.4

1.9

—

Viral encephalitis, not elsewhere classified/unspecified

14.66

8.22

1.5

1.3

—

Disorders of oesophagus in diseases classified elsewhere

14.64

8.22

2.8

1.2

—

Glomerulonephritis

4.22

8.19

1.2

2.1

—

Invasive ventilation

7.54

8.15

1.3

2.1

—

Diseases of the eye and adnexa

227

2.03

8.12

2.0

1.9

—

Valvular heart disease excluding rheumatic fever

206

2.26

8.11

1.8

—

Bacterial, viral and other infectious agents

4.54

8.11

2.3

2.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

149

2.46

8.06

2.2

2.3

—

Benign neoplasm of other and ill-defined parts of digestive system

3.38

8.05

2.6

2.0

—

Hypercalcemia

8.96

8.04

1.9

1.6

—

Asthma and opportunity respiratory infection

8.96

8.04

2.8

1.9

—

Basal cell carcinoma, including Hilmo

149

2.46

8.02

2.8

2.4

—

Diseases of arteries, arterioles and capillaries

332

1.97

7.91

1.9

2.0

—

Other disorders of conjunctiva

3.70

7.88

1.8

1.9

—

Insulin medication

357

1.98

7.85

2.4

1.9

—

Ischaemic heart disease, wide definition

103

336

1.89

7.82

2.4

2.0

—

Haemolytic anaemias

10.86

7.80

1.9

2.2

—

Benign neoplasms

123

373

1.80

7.77

2.3

1.8

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

3.87

7.69

1.5

1.6

—

Cardiodefibrillation

216

2.36

7.58

2.4

2.0

—

Other dialysis

10.11

7.54

1.1

2.4

—

Pneumonitis due to solids and liquids

6.15

7.53

1.9

1.7

—

Depression medications

3.88

7.51

2.1

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

340

2.04

7.51

2.2

1.9

—

Other diseases of intestines

130

416

1.74

7.48

2.2

1.9

—

Osteoporosis with pathological fracture (FG)

7.11

7.47

2.2

1.3

—

Demyelinating diseases of the central nervous system

4.24

7.47

1.6

2.0

—

Carcinoma in situ of skin of other and unspecified parts of face

6.45

7.40

3.5

1.5

—

Abnormal findings on examination of blood, without diagnosis

291

2.09

7.30

2.4

2.1

—

SLE, strict definition

10.93

7.30

1.9

1.6

—

SLE, ICD10

10.93

7.30

1.9

1.6

—

Actinic keratosis

183

2.39

7.23

3.0

1.6

—

Functional dyspepsia

144

2.64

7.19

3.1

1.6

—

Tuberculosis, IBD comorbidity

7.31

7.18

2.1

2.0

—

Rheumatoid arthritis, including avohilmo

217

2.31

7.11

1.2

1.9

—

12.14

7.09

2.8

1.6

—

Speech disturbances, not elsewhere classified

5.61

7.05

1.3

1.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

4.20

7.00

1.7

2.2

—

Vitreous haemorrhage

4.20

7.00

1.5

2.1

—

Viral and other specified intestinal infections

104

2.91

6.99

2.2

1.8

—

Nonsuppurative otitis media

115

2.72

6.98

1.9

1.7

—

Obesity related asthma

219

2.29

6.97

2.7

1.8

—

Pain in limb

111

399

1.77

6.97

2.3

1.9

—

Elevated blood glucose level

4.37

6.95

2.6

2.3

—

Other infectious diseases

5.83

6.90

1.4

2.4

—

Seropositive rheumatoid arthritis

135

2.66

6.88

1.1

1.9

—

Neurological diseases, wide definition

3.25

6.83

2.3

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

6.71

6.81

1.8

1.9

—

Disorders resulting from impaired renal tubular function

9.36

6.79

2.0

2.4

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

137

2.63

6.78

1.1

1.9

—

Other neurological diseases

395

1.83

6.77

1.7

2.0

—

Antihypertensive medication - note that there are other indications

179

2.07

6.76

2.6

1.2

—

Need for immunization against other single viral diseases

16.88

6.76

2.2

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

134

2.39

6.75

2.0

1.5

—

Pneumonia due to Streptococcus pneumoniae

16.75

6.74

1.3

—

Other disorders of white blood cells

7.18

6.70

2.2

2.0

—

Other diseases of intestine

3.21

6.68

2.0

1.6

—

Other disorders of eyelid

228

2.19

6.66

2.0

1.8

—

Insulin, fast-acting

211

2.28

6.64

2.6

1.9

—

Disorders of other endocrine glands

271

2.11

6.64

1.6

1.8

—

Other and unspecified iron deficiency

186

2.36

6.63

2.2

1.8

—

Tuberculosis, wide

6.43

6.63

2.1

1.9

—

Asthma and allergy, excluding more controls

6.33

6.55

2.3

1.1

—

Asthma and allergy

6.33

6.55

2.3

1.1

—

Symptoms and signs involving the digestive system and abdomen

118

342

1.73

6.54

2.0

—

Tuberculosis

6.85

6.51

1.9

2.0

—

Chronic periodontitis, including avohilmo

122

463

1.68

6.46

2.4

1.9

—

Symptoms and signs involving the urinary system

406

1.78

6.46

2.1

2.0

—

Tuberculosis, wide, including avohilmo

6.18

6.46

2.1

1.9

—

208

2.21

6.45

3.0

1.6

—

Streptococcal septicaemia

5.69

6.44

1.6

2.1

—

Drug-induced osteoporosis

14.54

6.42

2.4

1.4

—

Personal history of other diseases and conditions

5.28

6.42

3.2

1.0

—

Respiratory conditions due to other external agents

14.45

6.41

1.5

2.0

—

Missing teeth due to accident, extraction or parodontitis

396

1.85

6.40

2.3

1.9

—

Periodontitis

122

464

1.68

6.39

2.4

1.9

—

Skin changes due to chronic exposure to nonionizing radiation

193

2.25

6.39

3.0

1.6

—

Syncope and collapse

161

2.33

6.38

1.9

1.8

—

Other/unspecified seropositive rheumatoid arthritis

142

2.54

6.33

1.1

1.9

—

Acute tubulo-interstitial nephritis

309

1.94

6.33

1.8

—

Other specified/unspecified systemic involvement of connective tissue

6.56

6.33

2.6

1.3

—

Acquired haemolytic anaemia

11.11

6.30

1.5

1.3

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

11.05

6.29

1.5

2.5

—

Streptococcal septicaemia, including avohilmo

5.50

6.29

1.6

2.1

—

Glaucoma secondary to other eye disorders

9.29

6.29

1.0

2.4

—

Nonsuppurative otitis media, including avohilmo

158

2.36

6.27

1.9

1.7

—

Disorders of muscles

3.66

6.19

1.7

1.9

—

In situ neoplasms

231

2.17

6.18

2.8

1.6

—

Asthma, including avohilmo

142

486

1.61

6.18

2.5

1.8

—

Diverticular disease of intestine

300

1.83

6.17

2.2

2.0

—

Seropositive rheumatoid arthritis, wide

144

2.50

6.16

1.1

1.9

—

Neurological diseases

253

1.83

6.12

2.1

2.0

—

Codeine or tramadol medication

135

451

1.63

6.11

2.3

1.8

—

Diseases of spleen

12.66

6.09

1.1

1.6

—

Persons encountering health services for examination and investigation

162

2.04

6.04

2.1

1.5

—

Phlebitis and thrombophlebitis (not including DVT)

122

2.63

6.04

2.3

1.8

—

Systemic lupus erythematosus, unspecified

10.08

6.04

2.0

1.6

—

Keratitis

214

2.20

6.03

1.9

2.0

—

Other embolism and thrombosis

3.34

5.99

1.8

2.0

—

Diplopia

3.34

5.99

1.7

2.0

—

Other symptoms and signs involving the digestive system and abdomen

2.93

5.98

2.1

1.7

—

Squamous cell neoplasms and carcinomas of the skin

6.01

5.98

1.7

1.9

—

Basal cell carcinoma

142

2.26

5.93

2.5

2.3

—

Insulin, fast-acting or short human

222

2.16

5.93

2.6

1.9

—

DVT of lower extremities

2.85

5.92

2.2

2.1

—

Mature T/NK-cell lymphomas, hilmo

15.23

5.92

1.4

1.3

—

Other and unspecified drugs and medicaments

4.01

5.89

1.6

2.0

—

Adjustment and management of implanted device

3.52

5.87

2.1

1.6

—

Seropositive rheumatoid arthritis, strict definition

3.20

5.86

1.2

2.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.29

5.85

2.2

2.0

—

Dialysis

8.05

5.84

1.2

2.2

—

Myeloproliferative diseases (CML excluded)

5.36

5.84

1.4

1.8

—

Hypersensitivity pneumonitis due to organic dust

11.27

5.81

4.4

1.8

—

Hodgkin lymphoma, hilmo

9.24

5.79

1.3

2.0

—

Delirium, not induced by alcohol and other psychoactive substances

3.78

5.78

1.5

2.1

—

Statin medication

227

1.89

5.76

2.9

1.3

—

Other diseases of pericardium

6.88

5.73

2.1

1.8

—

Persons encountering health services for specific procedures, not carried out

4.87

5.73

3.1

1.6

—

Viral and other specified intestinal infections, including avohilmo

150

2.38

5.66

2.0

1.8

—

Neovascular glaucoma

7.54

5.63

1.0

2.2

—

Other systemic involvement of connective tissue (FG)

136

2.46

5.61

1.8

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.10

5.60

1.6

1.7

—

Angina pectoris

204

1.98

5.57

2.5

1.3

—

5-aminosalicylic acid

3.40

5.57

1.8

1.2

—

Symptoms and signs concerning food and fluid intake

5.00

5.54

1.9

—

Other superficial mycoses

10.09

5.54

4.0

2.6

—

Use of hypnotics and sedatives

127

453

1.60

5.54

2.1

2.0

—

Other complications of surgical and medical care, not elsewhere classified

3.63

5.47

2.3

2.1

—

Malignant neoplasm of breast

2.44

5.46

1.1

2.1

—

Ulcerative colitis, NAS

2.90

5.45

2.0

1.8

—

Other demyelinating diseases of the central nervous system

7.10

5.44

2.0

1.4

—

Chronic myeloproliferative disease

16.23

5.42

1.1

1.6

—

Other disorders of optic [2nd] nerve and visual pathways

5.20

5.38

2.3

1.8

—

Benign neoplasm: Skin of other and unspecified parts of face

3.73

5.36

2.1

1.7

—

Pericarditis

7.91

5.34

2.5

1.9

—

Melanocytic naevi, other sites/unspecified

3.55

5.32

3.1

2.0

—

Persons with potential health hazards related to communicable diseases

217

2.10

5.32

2.1

1.8

—

Hypokalaemia

3.55

5.32

1.2

1.6

—

Other coagulation defects

4.72

5.29

2.2

2.1

—

Other peripheral vascular diseases

4.72

5.29

1.8

1.6

—

Speech therapy

143

2.38

5.28

2.8

1.8

—

Presence of other devices

2.85

5.28

1.7

1.1

—

Disorders of thyroid, IBD co-morbidities

3.52

5.28

2.4

1.2

—

Other leukaemias of specified cell type

+∞

5.25

1.6

0.0

—

Type 1 diabetes

131

2.44

5.25

1.5

1.9

—

Other soft tissue disorders, not elsewhere classified

115

404

1.62

5.25

2.4

1.9

—

Hernia

108

440

1.63

5.24

1.9

—

Raynaud syndrome

3.65

5.20

1.6

1.8

—

Conjunctivitis (acute, non atopic)

169

2.24

5.15

1.7

1.8

—

Other systemic involvement of connective tissue

145

2.35

5.13

1.8

—

Other and unspecified vascular occlusions

4.85

5.11

1.7

1.9

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

13.59

5.10

1.6

1.5

—

Benign neoplasm: Stomach

3.76

5.08

2.1

1.6

—

Rheumatoid arthritis

202

2.06

5.08

1.2

1.9

—

Dermatitis due to substances taken internally

5.21

5.08

2.7

2.1

—

Use of antiglaucoma preparations and miotics

5.20

5.07

1.6

1.8

—

Abdominal and pelvic pain

111

342

1.63

5.07

2.2

2.0

—

Infections of the skin and subcutaneous tissue

422

1.75

5.04

2.0

—

Malignant neoplasm of breast, HER2-negative

2.37

5.04

1.1

2.1

—

Other arrhythmias

305

1.79

5.04

2.3

1.8

—

Other and unspecified diseases of blood and blood-forming organs

10.07

5.03

1.0

2.1

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

10.05

5.02

1.9

2.7

—

Sequelae of external causes of morbidity and mortality

147

2.32

4.99

1.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

113

448

1.59

4.97

1.9

2.0

—

Melanocytic naevi of trunk

2.97

4.97

2.9

1.8

—

Other and unspecified disorders of white blood cells

6.91

4.95

2.5

2.3

—

Atrial fibrillation and flutter with reimbursement

2.68

4.94

2.4

1.3

—

Polyuria

123

2.44

4.94

2.2

2.0

—

Low back pain

387

1.66

4.94

1.9

—

Other degenerative diseases of the nervous system

100

2.41

4.93

1.9

—

Cerebrovascular diseases

372

1.68

4.93

1.8

2.1

—

Mood disorders, excluding more controls

109

398

1.61

4.92

2.1

1.9

—

Other and unspecified coagulation defects

6.03

4.91

2.2

1.8

—

Respiratory tuberculosis, confirmed and not-confirmed

6.03

4.91

2.2

2.1

—

Respiratory tuberculosis

6.03

4.91

2.2

2.1

—

Other CVD (FINNGEN)

4.53

4.90

3.1

1.1

—

Abnormal results of function studies

3.49

4.89

2.9

2.0

—

Subjective visual disturbances

136

2.36

4.88

2.1

1.9

—

Benign neoplasm: Colon

344

1.80

4.88

2.4

1.9

—

Cutaneous abscess, furuncle and carbuncle

149

2.29

4.84

1.6

1.8

—

Nasal polyp

2.70

4.83

2.4

1.7

—

Benign neoplasm: Ascending colon

2.99

4.82

2.3

1.8

—

Later onset COPD, excluding more controls

3.81

4.81

1.7

1.1

—

Disorders of vitreous body and globe

335

1.81

4.79

1.9

2.0

—

Malignant neoplasm of mesothelium and soft tissue

11.48

4.78

1.3

1.7

—

Other epidermal thickening

5.74

4.75

2.5

1.8

—

Urticaria and erythema

223

2.02

4.73

2.6

1.7

—

Other disorders of urethra and urinary system

331

1.70

4.70

2.1

1.9

—

Diseases of the digestive system

291

1.88

4.68

1.8

2.0

—

Other and unspecified tonsillitis

156

2.13

4.68

1.5

1.8

—

Volume depletion

4.68

4.67

2.2

1.7

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

101

2.28

4.67

1.1

2.1

—

Malignant neoplasm of breast, including Hilmo

101

2.28

4.67

1.1

2.1

—

L01XX Other antineoplastic agents

5.02

4.63

1.0

1.9

—

Noninfective enteritis and colitis

309

1.84

4.60

2.1

1.9

—

Benign neoplasm of colon, rectum, anus and anal canal

377

1.70

4.60

2.3

1.9

—

Congenital malformations of the circulatory system

2.70

4.59

3.0

1.8

—

Other inflammation of eyelid

2.90

4.59

1.5

1.8

—

Malignant immunoproliferative diseases

14.23

4.59

1.6

—

Dermatopolymyositis (FG)

14.15

4.58

3.1

1.4

—

Fentanyl

4.52

4.54

1.9

1.7

—

GI-bleeding

173

2.14

4.53

1.6

1.8

—

Respiratory tuberculosis, confirmed

10.09

4.53

1.4

—

Respiratory tuberculosis, confirmed, including avohilmo

10.09

4.52

1.4

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

10.09

4.52

1.4

—

Gout, FINNGEN

153

2.21

4.50

2.3

2.2

—

Cerebral cysts

4.83

4.49

1.8

2.3

—

Other specified/unspecified bacterial intestinal infections

4.83

4.49

1.8

1.7

—

Lung cancer and mesothelioma

4.25

4.46

2.3

1.0

—

Diseases of peritoneum

3.27

4.46

1.4

2.0

—

Weight loss

3.42

4.46

2.3

1.9

—

Other disorders of pigmentation

5.82

4.44

3.6

1.4

—

conjunctival haemorrhage

4.39

4.43

2.0

—

Other noninfective gastroenteritis and colitis

130

2.31

4.40

2.2

2.0

—

Hypothyroidism, drug reimbursement

5.05

4.37

2.0

1.1

—

Parasetamol

211

1.75

4.37

2.0

1.5

—

Sequelae with surgical and medical care as external cause

106

2.46

4.36

1.9

—

Myositis

7.55

4.36

1.1

1.3

—

Family history of certain disabilities and chronic diseases leading to disablement

7.52

4.35

1.0

—

Other symptoms and signs involving the circulatory and respiratory systems

5.01

4.31

2.6

1.5

—

Mood [affective] disorders

118

497

1.52

4.31

2.0

—

Hepatic failure, not elsewhere classified

6.28

4.29

1.5

2.1

—

Generalized skin eruption due to drugs and medicaments

5.53

4.29

2.8

2.4

—

Human immunodeficiency virus [HIV] disease

8.97

4.29

1.1

3.9

—

Human immunodeficiency virus [HIV] disease, including avohilmo

8.97

4.29

1.1

3.9

—

Mood disorders

118

497

1.52

4.28

2.0

—

Myocarditis

8.91

4.28

1.5

1.2

—

Other benign neoplasms of skin

239

1.93

4.27

2.3

1.8

—

Hypertensive diseases

321

1.62

4.25

2.3

1.9

—

Other diseases of blood and blood-forming organs

4.50

4.24

1.7

2.4

—

Misadventures to patients during surgical and medical care

2.84

4.21

1.3

1.9

—

Acute generalized exanthematous pustulosis

4.82

4.18

2.7

2.2

—

Allergic urticaria

3.42

4.18

2.0

1.6

—

Acute gastritis

4.81

4.18

2.3

1.6

—

Hyperlipidaemia, other/unspecified

209

1.94

4.17

2.0

1.8

—

Ulcerative colitis

134

2.24

4.14

2.1

1.9

—

Other disorders of kidney and ureter

2.99

4.11

1.8

1.9

—

Cerebral palsy and other paralytic syndromes

2.99

4.11

1.5

1.9

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

152

2.15

4.10

1.3

1.8

—

Visual field defects

4.01

4.09

1.4

2.1

—

Hypertension

321

1.60

4.05

2.3

1.9

—

Deviated nasal septum

209

1.96

4.02

1.9

2.1

—

Dermatopolymyositis

10.10

4.02

3.1

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

182

2.03

4.02

2.2

1.7

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

109

480

1.52

4.00

2.1

2.0

—

Other diseases of stomach and duodenum

5.02

4.00

2.5

1.6

—

Diseases of tongue

5.01

4.00

1.4

1.5

—

Disorders of gallbladder, biliary tract and pancreas

112

461

1.51

3.99

2.2

1.9

—

Disorders of vitreous body

329

1.74

3.99

1.8

2.0

—

Finngen Rheumatological endpoints

106

392

1.53

3.98

1.8

2.0

—

Optic neuritis

5.58

3.97

1.0

1.4

—

Oesophagitis

5.57

3.97

1.5

1.7

—

Diabetic retinopathy, excluding more controls

2.15

3.95

1.7

2.4

—

Lower back pain or/and sciatica

121

507

1.48

3.94

2.0

1.9

—

Acute peritonitis

4.46

3.93

1.5

2.1

—

Cellulitis

118

2.29

3.93

2.2

1.7

—

Localized swelling, mass and lump of skin and subcutaneous tissue

184

2.01

3.91

2.0

1.9

—

Noninfectious colitis NAS

2.72

3.91

2.1

1.8

—

Tumor necrosis factor alpha inhibitors

100

2.40

3.88

1.3

2.0

—

Hypothyroidism (congenital or acquired)

3.05

3.87

1.3

1.0

—

Papilloedema, unspecified

7.33

3.86

2.9

1.6

—

Other and unspecified injuries of shoulder and upper arm

7.31

3.86

3.8

2.5

—

Deforming dorsopathies

185

2.00

3.86

2.2

1.8

—

Myocardial infarction

180

1.86

3.83

2.1

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

6.03

3.81

3.1

1.0

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

6.02

3.81

1.9

2.1

—

Paralytic strabismus

4.30

3.81

1.4

1.9

—

Ascites

4.30

3.81

1.3

1.5

—

Congenital malformations of cardiac septa

4.32

3.81

2.2

2.1

—

Inflammatory bowel disease

193

1.97

3.80

2.1

1.9

—

Blepharochalasis

146

2.13

3.79

2.1

1.7

—

Diseases of middle ear and mastoid

310

1.69

3.77

1.9

—

Other specified/unspecified necrotizing vasculopathies

12.12

3.77

1.2

1.4

—

Other congenital malformations

3.19

3.77

2.2

1.9

—

Other problems related to primary support group, including family circumstances

2.94

3.76

1.0

2.1

—

Chronic pancreatitis

2.73

3.75

3.7

1.6

—

Other symptoms and signs involving cognitive functions and awareness

279

1.75

3.74

1.6

1.9

—

Other diseases of the digestive system

174

2.01

3.72

1.6

1.8

—

Unspecified haematuria

220

1.81

3.71

2.1

2.0

—

Disorders of lipoprotein metabolism and other lipidaemias

327

1.58

3.70

2.2

1.9

—

Diabetes, varying definitions

113

441

1.49

3.69

2.1

1.9

—

Disturbances of skin sensation

161

2.05

3.69

2.3

1.9

—

Carcinoma in situ of skin of upper limb, including shoulder

6.71

3.68

1.5

1.4

—

Other and unspecified epidermal thickening

6.71

3.67

3.3

2.1

—

Endocarditis

6.69

3.67

1.0

2.1

—

Malignant neoplasm of stomach, including Hilmo

6.68

3.67

1.9

2.4

—

Other specified and unspecified retinal disorders

5.65

3.66

1.8

2.3

—

FESS (DNB20)

2.69

3.65

2.6

1.5

—

Ethmoidectomy

2.69

3.65

2.6

1.5

—

Unspecified privation

2.86

3.62

2.3

1.9

—

Abnormal findings on diagnostic imaging of other body structures

2.86

3.62

1.1

1.7

—

Sequelae of other external causes

4.41

3.62

1.6

1.9

—

Suggestive for eosinophilic asthma

3.51

3.60

1.6

1.9

—

Ptosis of eyelid

3.51

3.60

1.8

1.7

—

Major coronary heart disease event excluding revascularizations

217

1.73

3.58

2.1

1.3

—

Sub-endpoint used in defining T1D endpoints

147

2.08

3.58

1.5

1.8

—

Osteonecrosis due to drugs

7.86

3.56

1.7

1.9

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.85

3.56

1.1

3.9

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

7.85

3.56

1.1

3.9

—

Other melanin hyperpigmentation

7.83

3.56

3.4

1.4

—

Systemic sclerosis, icd10

7.83

3.56

3.0

1.8

—

Systemic sclerosis

7.83

3.56

3.0

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

4.77

3.55

3.2

2.0

—

Glaucoma

310

1.67

3.53

1.5

1.9

—

Cardiomyopathy

2.50

3.53

1.4

1.7

—

Other arthritis (FG)

199

1.91

3.51

1.4

1.9

—

Acute pharyngitis

2.72

3.51

1.1

1.5

—

Other diseases of spinal cord

6.19

3.50

2.1

2.3

—

Chronic apical periodontitis

121

468

1.45

3.50

1.8

1.9

—

Viral conjunctivitis

10.06

3.50

1.3

1.5

—

Depression

107

485

1.47

3.49

2.1

2.0

—

Corneal ulcer

2.33

3.49

2.1

1.9

—

Combinations of oral blood glucose lowering drugs

213

0.28

3.46

1.3

2.2

—

Aortic valve malfunction, age under 60 years

2.89

3.46

2.3

2.2

—

Gingivitis and periodontal diseases

102

351

1.50

3.44

1.8

—

Hyperkalaemia

4.56

3.43

2.9

1.3

—

Hypothyroidism, levothyroxine purchases

2.89

3.37

1.2

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.89

3.37

1.2

1.0

—

Fracture of rib(s), sternum and thoracic spine

181

1.94

3.37

2.1

2.0

—

Anaemia in chronic diseases classified elsewhere

7.04

3.36

1.9

—

Hordeolum and other deep inflammation of eyelid

4.36

3.30

2.8

1.6

—

Abnormal weight loss

3.43

3.30

2.5

1.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

397

1.61

3.30

1.7

2.0

—

Paralytic ileus and intestinal obstruction

141

2.06

3.30

2.3

1.7

—

Malignant neoplasm of breast, ER-positive, including Hilmo

2.20

3.29

1.1

2.1

—

Etanercept

3.65

3.29

1.5

2.1

—

Vulvovaginal ulceration/inflammation in other diseases

3.65

3.29

2.1

1.6

—

Lichen simplex chronicus and prurigo

3.94

3.28

1.7

—

Personal history of malignant neoplasm

3.94

3.28

1.3

1.0

—

Brain glioblastoma, helper endpoint

8.65

3.27

1.5

1.3

—

Pacemaker

176

1.90

3.26

1.9

1.8

—

AV-block

2.50

3.26

2.0

1.6

—

Peripheral artery operations in Hilmo

3.03

3.24

1.1

1.8

—

Nonischemic cardiomyopathy

3.03

3.24

2.2

1.9

—

Follicular lymphoma, hilmo

4.76

3.24

1.1

2.1

—

Diabetic nephropathy, excluding more controls

2.33

3.23

1.7

2.5

—

Dorsalgia

108

392

1.46

3.23

2.1

1.9

—

Other disorders of eye and adnexa

2.44

3.21

1.3

1.8

—

Other and unspecified iridocyclitis

4.18

3.19

1.1

2.5

—

Sequelae of infectious and parasitic diseases, including avohilmo

3.54

3.19

1.3

2.4

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

5.36

3.19

2.0

2.3

—

IgA nephropathy (IgA glomerulonephritis)

6.40

3.19

1.1

2.3

—

Systemic sclerosis (FG)

6.40

3.19

3.0

1.4

—

Benign neoplasm: Transverse colon

2.86

3.18

2.8

1.9

—

Endocrine, nutritional and metabolic diseases

260

1.55

3.17

2.3

1.7

—

Diabetes mellitus

111

445

1.44

3.16

2.1

1.9

—

Diabetic nephropathy

2.27

3.16

1.7

2.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.73

3.15

2.3

2.1

—

Exclusions for E4_PCOS_BROAD

104

2.21

3.14

1.6

1.9

—

Other diseases of urinary system

107

415

1.45

3.12

2.2

2.0

—

Melanocytic naevi of lower limb, including hip

4.52

3.11

3.2

1.6

—

Intestinal malabsorption

4.52

3.11

1.6

2.0

—

Need for other prophylactic measures

4.01

3.08

1.0

2.5

—

Tongue abnormality

4.01

3.08

1.4

1.9

—

Other functional intestinal disorders

249

1.72

3.07

1.4

1.6

—

Primary biliary cholangitis (PBC)

7.54

3.06

1.0

2.1

—

Chronic nephritic syndrome

5.02

3.05

1.5

2.2

—

Erythema nodosum

5.86

3.02

2.4

1.8

—

Idiopathic thrombocytopenic purpura

5.86

3.02

2.0

1.5

—

Simple and mucopurulent chronic bronchitis

5.85

3.02

2.1

1.7

—

Malignant neoplasm of stomach

5.85

3.02

2.0

2.4

—

Septal defects

3.93

3.02

2.4

2.2

—

Disorders of conjunctiva

481

1.47

3.01

1.9

—

Polymyositis

10.13

2.99

2.6

1.6

—

Other and unspecified acquired haemolytic anaemias

10.11

2.98

1.4

1.6

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

10.10

2.98

1.2

2.8

—

Other prurigo

10.09

2.98

1.0

1.4

—

Postzoster neuralgia

10.06

2.98

1.0

2.0

—

Insomnia

522

0.60

2.97

1.6

2.0

—

Other (seronegative) rheumatoid arthritis, wide

2.24

2.95

1.2

2.0

—

Diabetic retinopathy

137

1.81

2.93

1.6

2.2

—

Retinal breaks without detachment

2.28

2.93

1.2

2.0

—

Polycystic ovarian syndrome, consortium definition

253

1.56

2.93

2.0

1.6

—

Malignant neoplasm of breast, HER-positive

2.12

2.92

1.1

2.1

—

Bacterial meningitis

4.73

2.92

1.6

2.9

—

Chronic hepatitis, not elsewhere classified

4.73

2.92

1.3

2.2

—

Rash and other nonspecific skin eruption

2.83

2.91

2.7

1.7

—

Injuries to the thorax

326

1.63

2.89

2.2

2.1

—

Diseases of the ear and mastoid process

123

442

1.39

2.89

2.1

1.9

—

Exposure to unspecified factor

109

526

1.41

2.88

2.0

1.9

—

Melanocytic naevi of other and unspecified parts of face

3.71

2.88

1.1

1.9

—

Osteomyelitis

3.71

2.88

2.4

2.1

—

Other and unspecified glaucoma

3.71

2.87

1.3

1.8

—

Nephrotic syndrome

5.41

2.87

1.0

1.5

—

Chronic conjunctivitis

5.41

2.87

1.7

2.4

—

Primary Sclerosing Cholangitis, IBD and UDCA required

6.70

2.87

1.0

1.6

—

Prurigo nodularis

6.70

2.87

2.3

1.9

—

Other specified and unspecified disorders of eye and adnexa

5.40

2.87

1.3

2.4

—

Chronic tubulo-interstitial nephritis

5.40

2.87

1.1

1.8

—

Other retinal disorders

329

1.55

2.86

1.6

2.2

—

Other CVD

2.25

2.86

2.7

1.7

—

L04AC Interleukin inhibitors

3.17

2.85

1.4

2.2

—

Duodenal ulcer

3.16

2.84

1.3

1.6

—

Other disorders of bone

2.19

2.82

1.9

—

Unstable angina pectoris

144

1.86

2.82

2.2

1.3

—

Type 2 diabetes, wide definition

379

1.46

2.82

1.9

2.0

—

Acetic acid derivatives and related substances

144

0.36

2.81

1.1

2.3

—

Viral conjunctivitis, including avohilmo

4.46

2.79

1.3

2.2

—

Malignant melanoma

2.64

2.79

2.2

—

Other keratitis

2.47

2.78

1.2

2.0

—

Other superficial mycoses, including avohilmo

2.55

2.78

3.2

1.6

—

Hydrocephalus

3.58

2.78

1.2

1.7

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

3.58

2.78

2.6

2.2

—

Intestinal stricture

187

1.82

2.77

2.3

1.9

—

Varicella [chickenpox], including avohilmo

3.92

2.77

3.2

2.1

—

Polyarteritis nodosa and related conditions

8.40

2.75

1.2

1.3

—

Malignant neoplasm of testis, including Hilmo

8.38

2.75

1.0

3.0

—

6-mercaptopurine

8.35

2.75

1.6

1.0

—

Temporal arteritis

5.02

2.73

1.6

—

Other or unspecified ileus, impaction or obstruction

2.20

2.72

2.8

1.6

—

Other osteochondropathies

3.24

2.72

1.5

2.5

—

Symptoms and signs involving speech and voice

203

1.78

2.71

1.5

1.8

—

Complications of procedures, not elsewhere classified

446

1.46

2.71

1.6

2.0

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

6.03

2.70

2.5

2.3

—

Disorders of globe

6.03

2.70

2.7

1.4

—

Inguinal hernia, bilateral

2.60

2.70

2.4

2.2

—

Congenital malformations of heart and great arteries

2.36

2.69

2.6

2.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

3.46

2.69

2.0

1.7

—

Varicella [chickenpox]

4.22

2.68

2.9

2.3

—

Oesophageal varices

3.76

2.67

1.7

2.3

—

Urethral stricture

3.76

2.67

2.9

2.0

—

Acute nasopharyngitis (common cold)

2.48

2.65

1.8

1.9

—

Other diseases of arteries and capillaries

3.15

2.64

1.7

1.8

—

Disorders of skin appendages

349

1.57

2.62

2.7

1.9

—

Disorders of parathyroid gland

2.12

2.62

1.5

1.8

—

Nail disorders

2.66

2.62

3.8

2.0

—

Carcinoma in situ of skin of trunk

4.69

2.60

1.9

1.5

—

Manic episode

4.69

2.60

2.6

2.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

274

1.64

2.60

1.8

1.9

—

Giant cell arteritis with polymyalgia rheumatica

4.68

2.60

1.6

1.8

—

Adrenocortical insufficiency

4.68

2.60

1.1

1.5

—

Speech and linguistic disorders, excluding more controls

3.35

2.59

2.4

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

394

1.52

2.58

2.4

1.9

—

Episodal and paroxysmal disorders

110

402

1.39

2.57

2.3

1.8

—

Other abnormal findings of blood chemistry

4.01

2.56

3.8

1.9

—

Juvenile arthritis (FINNGEN)

4.01

2.56

1.0

1.7

—

Other aneurysm

4.01

2.56

2.9

1.8

—

Disorders of speech understanding and production

4.59

2.55

1.7

1.5

—

Background retinopathy and retinal vascular changes

7.18

2.55

1.6

—

Hypotension

2.35

2.55

3.1

1.8

—

Conduction disorders

135

1.84

2.55

1.8

1.7

—

Haemorrhage, not elsewhere classified

5.47

2.54

1.5

2.5

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.73

2.54

1.3

2.0

—

Impacted cerumen

2.73

2.54

1.3

1.6

—

Irregular menses

222

1.62

2.54

2.0

1.6

—

Amputation

2.86

2.54

1.1

1.9

—

Coxibs

146

0.39

2.53

1.2

2.3

—

Benign neoplasm of eye and adnexa

2.60

2.53

1.5

2.0

—

Cervicocranial syndrome

2.50

2.52

2.1

2.0

—

Inguinal or femoral hernia, bilateral

2.50

2.52

2.4

2.3

—

Heart failure and bmi 25plus

131

1.78

2.51

2.1

—

Amenorrhoea

3.23

2.51

1.7

1.8

—

Myocardial infarction, strict

166

1.71

2.51

2.0

1.3

—

Sleep disorders

527

0.64

2.50

1.6

2.0

—

Superficial injury of head

129

1.94

2.48

1.2

1.9

—

Cholangitis (primary sclerosing, PSC)

3.47

2.48

1.3

1.5

—

Visual impairment including blindness (binocular or monocular)

3.47

2.48

1.3

1.9

—

Malignant neoplasm of kidney, except renal pelvis

3.47

2.48

2.8

2.3

—

Hypoparathyroidism

4.39

2.47

2.1

1.6

—

Other congenital malformations, including avohilmo

2.32

2.47

2.8

1.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

3.18

2.46

2.9

1.9

—

Abnormal findings on examination of urine, without diagnosis

3.82

2.46

2.5

1.9

—

Other diseases of anus and rectum

172

1.80

2.46

1.9

1.6

—

Atrial septal defect

4.36

2.46

2.1

2.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

256

0.39

2.46

3.5

2.1

—

Glucagon-like peptide-1 (GLP-1) analogues

256

0.39

2.46

3.5

2.1

—

Spondylopathies

342

1.43

2.42

2.0

—

Exclusions for E4_PCOS_CONSORTIUM

295

1.48

2.42

1.7

1.8

—

Malignant neoplasm of urinary organs, including Hilmo

2.90

2.41

3.2

2.5

—

Degenerative macular diseases

2.90

2.41

2.2

1.8

—

Benign neoplasm: Duodenum

5.02

2.40

2.0

1.5

—

Hypertension, essential

313

1.44

2.40

2.1

1.9

—

Malignant neoplasm of urinary organs

3.34

2.39

2.8

2.3

—

Obstructive hydrocephalus

6.29

2.37

1.2

1.4

—

Other specified/unspecified deforming dorsopathies

6.28

2.37

2.0

2.9

—

Other localized connective tissue disorders

6.28

2.37

1.0

1.4

—

Viral agents as the cause of diseases classified to other chapters

6.28

2.37

2.8

1.5

—

Lesion of lateral popliteal nerve

3.65

2.36

3.1

2.2

—

Viral meningitis

4.13

2.36

2.0

2.8

—

Benign neoplasm: Small intestine

4.13

2.36

1.9

2.1

—

Viral meningitis, including avohilmo

4.13

2.36

2.0

2.8

—

Giant cell arteritis

4.13

2.36

1.6

1.5

—

Other congenital malformations of skin

4.13

2.36

2.6

1.5

—

Herpesviral keratitis and keratoconjunctivitis

4.13

2.36

2.1

—

Other juvenile arthritis

4.13

2.36

1.0

1.8

—

Somnolence, stupor and coma

4.13

2.36

1.4

2.1

—

Other specified/unspecified hearing loss

3.04

2.35

1.5

1.8

—

Symptoms and signs involving the nervous and musculoskeletal systems

418

1.48

2.34

1.7

2.0

—

Thoracic aortic aneurysm

2.26

2.34

2.7

2.1

—

Childhood asthma (age<16)

2.87

2.31

2.2

1.1

—

Childhood asthma (age<16), excluding more controls

2.87

2.31

2.2

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2.05

2.30

2.4

1.8

—

Other disorders of nervous system

3.22

2.30

2.0

1.8

—

Corns and callosities

3.22

2.30

1.1

1.9

—

Primary gonarthrosis, bilateral

344

0.53

2.30

1.4

2.0

—

Diseases of the myoneural junction and muscle

2.38

2.29

1.3

2.1

—

Impotence

2.95

2.28

4.4

2.1

—

Sequelae of infectious and parasitic diseases

2.95

2.28

1.4

2.4

—

Malignant neoplasm of head and neck, including Hilmo

2.94

2.27

1.3

2.1

—

Cardiomyopathies, Primary/intrinsic

2.46

2.27

1.5

1.7

—

Artificial opening status

4.62

2.27

2.7

1.2

—

Convalescence

4.62

2.27

2.5

1.7

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

2.75

2.27

2.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.22

2.27

1.9

2.1

—

Vascular disorders of the intestines

3.48

2.26

1.3

1.6

—

Special screening examination for other diseases and disorders

2.55

2.26

2.2

1.3

—

Gout

171

1.71

2.25

2.3

2.2

—

Diabetes medication

107

462

1.35

2.24

2.1

1.9

—

Other/unspecified reactive arthropathies

3.11

2.22

2.8

1.7

—

Pain in joint

236

1.51

2.22

1.9

1.7

—

Scleritis

5.60

2.22

1.0

2.8

—

Other and unspecified disorders of vitreous body

280

1.57

2.21

1.8

1.9

—

Erythema multiforme

5.58

2.21

5.2

1.8

—

Malnutrition

5.58

2.21

1.4

1.3

—

Primary biliary cholangitis, wide definition

5.58

2.21

1.0

3.0

—

Juvenile rheumatoid arthirtis

5.58

2.21

1.0

2.2

—

Other and unspecified nail disorders

5.58

2.21

4.8

1.7

—

Other diseases of lip and oral mucosa

287

1.57

2.21

1.9

1.8

—

Erectile dysfunction

2.86

2.20

1.0

2.0

—

Follow-up examination after treatment for malignant neoplasms

2.86

2.20

1.3

1.2

—

Chronic periodontitis, complicated

421

1.46

2.20

2.5

2.0

—

Hypoplasia of dental enamel , including avohilmo

4.45

2.19

2.8

1.2

—

Molar incisor enamel hypoplasia

4.42

2.18

2.8

1.2

—

Perforation of tympanic membrane

2.50

2.18

1.8

2.0

—

Neuralgia and neuritis, unspecified

3.34

2.18

1.8

1.5

—

Ingrowing nail

3.34

2.18

3.7

2.5

—

Decubitus ulcer and pressure area

3.34

2.18

2.0

1.8

—

Ulcer of oesophagus

3.34

2.18

2.0

1.6

—

Stroke, excluding SAH

304

1.47

2.17

1.6

2.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

2.06

2.17

2.3

—

Type 2 diabetes

101

431

1.36

2.16

1.8

1.9

—

Other endocrine disorders

3.34

2.16

1.9

1.7

—

Speech and linguistic disorders

2.82

2.16

2.4

2.1

—

Amputation of foot

4.30

2.15

1.0

2.0

—

Respiratory tuberculosis, not confirmed

4.30

2.15

3.0

1.7

—

Respiratory tuberculosis, not confirmed, including avohilmo

4.30

2.15

3.0

1.7

—

Scleritis and episcleritis

3.01

2.14

1.1

2.5

—

Benign neoplasm: Choroid

3.01

2.14

1.7

—

Amputation of toe

3.01

2.14

1.1

1.8

—

Malignant neoplasm of head and neck

3.00

2.14

1.3

2.2

—

Bell's palsy

2.30

2.14

1.6

2.0

—

Other diseases of hard tissues of teeth

162

1.57

2.14

1.7

1.8

—

Infectious mononucleosis, including avohilmo

2.78

2.13

1.0

2.6

—

Infectious mononucleosis

2.78

2.13

1.0

2.6

—

Aortic aneurysm

113

1.91

2.13

2.4

2.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.10

2.12

1.9

2.1

—

Cardiomyopathy (excluding other)

2.37

2.12

1.5

1.9

—

Valvular operations

2.37

2.11

1.3

1.8

—

Pure hypercholesterolaemia

310

1.43

2.11

2.1

1.8

—

Other and unspecified visual disturbances

2.45

2.10

1.2

2.0

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

3.21

2.09

1.3

2.6

—

Other and unspecified disorders of skin and subcutaneous tissue

3.21

2.09

2.9

1.7

—

Constipation

452

1.36

2.09

2.0

—

Fitting and adjustment of other devices

140

1.76

2.08

2.0

1.7

—

Amiodarone users

2.56

2.07

1.9

1.8

—

Unspecified nephritic syndrome

5.02

2.07

1.0

1.3

—

Paraplegia, diplegia of upper limbs

5.02

2.07

1.2

2.5

—

Chronic Coagulation defects

5.02

2.07

1.6

1.8

—

5.02

2.07

1.2

2.6

—

Asthma mixed form (mode)

5.01

2.07

1.6

1.0

—

Asthma mixed form (mode), excluding more controls

5.01

2.07

1.6

1.0

—

Appendectomy

484

0.61

2.07

2.3

1.9

—

MS-disease / Multiple Sclerosis

2.71

2.07

1.0

2.2

—

Pyogenic arthritis

2.71

2.07

1.1

2.1

—

Diseases of salivary glands

206

1.65

2.06

2.2

1.8

—

Unknown and unspecified causes of morbidity

3.51

2.05

1.7

2.3

—

Spondylolisthesis/Spondylolysis

110

1.91

2.05

2.4

1.9

—

Any mental disorder

107

401

1.34

2.05

2.0

1.9

—

Mixed conductive and sensorineural hearing loss

2.32

2.04

1.5

1.9

—

Myocardial infarction, unclassifiable

2.13

2.04

1.8

—

Other disorders of prostate

4.01

2.04

1.5

2.1

—

Autoimmune hepatitis, wide definition

4.01

2.04

2.3

2.2

—

Abnormalities of forces of labour

0.00

2.03

0.0

1.6

—

Fracture of lumbar spine and pelvis

110

1.91

2.03

1.1

1.7

—

Caries of enamel

102

500

1.33

2.03

1.9

2.0

—

Malignant neoplasm of bladder, including Hilmo

2.67

2.03

3.0

2.6

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

438

1.41

2.02

2.4

1.9

—

Seborrhoeic dermatitis

2.40

2.02

2.9

1.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

331

1.50

2.02

1.8

1.9

—

Entropion and trichiasis of eyelid

3.08

2.01

1.9

1.3

—

Collagenous colitis

2.50

2.01

2.5

2.0

—

Fibrosis and cirrhosis of liver

2.64

2.00

2.0

1.8

—

Other anxiety disorders

243

1.54

1.98

2.4

1.9

—

Other disorders of adrenal gland

3.34

1.96

1.1

2.0

—

Other lack of coordination

4.57

1.94

1.6

1.7

—

Disorders of optic nerve, not elsewhere classified

4.57

1.94

2.0

1.8

—

Other misadventures during surgical and medical care

4.56

1.94

1.6

—

Carcinoma in situ of skin of scalp and neck

4.56

1.94

3.8

1.3

—

Benign neoplasm: Skin of lower limb, including hip

4.56

1.94

2.6

1.6

—

LSIL lesion of the vulva

4.56

1.94

2.0

1.8

—

Other and unspecified corneal deformities and disorders

4.56

1.94

1.2

1.6

—

Disorders of eyelid in diseases classified elsewhere

4.56

1.94

2.2

1.5

—

Malignant neoplasm of oral cavity, including Hilmo

4.55

1.94

1.2

2.3

—

Sixth [abducent] nerve palsy

3.76

1.93

1.8

1.9

—

Arthropathies in other diseases classified elsewhere

3.76

1.93

1.8

2.3

—

Other inflammation of eyelid, including avohilmo

273

1.54

1.93

1.9

1.7

—

Complications of other internal prosthetic devices, implants and grafts

3.76

1.93

2.0

1.7

—

Chronic ulcer of skin, not elsewhere classified

2.97

1.93

1.9

2.0

—

Other and unspecified psoriasis

2.73

1.93

2.4

2.2

—

Dermatophytosis, including avohilmo

444

1.41

1.93

1.8

1.9

—

Dental operations

178

1.50

1.92

1.8

—

Diseases of liver

234

1.58

1.92

1.9

2.0

—

Stroke, including SAH

323

1.42

1.91

1.7

2.1

—

External causes of morbidity and mortality

223

1.44

1.90

2.0

—

Chronic laryngitis and laryngotracheitis

2.24

1.90

1.8

1.5

—

Gout, idiopatic and unspecified

135

1.78

1.90

2.5

2.0

—

Inguinal hernia

266

1.45

1.89

2.2

2.1

—

Other specified/unspecified arthritis

196

1.63

1.89

1.5

2.0

—

Malignant melanoma, including Hilmo

2.16

1.87

2.2

2.1

—

Urticaria

181

1.66

1.87

2.3

1.7

—

Conjunctivitis

440

1.37

1.87

2.0

1.9

—

Nerve, nerve root and plexus disorders

107

491

1.31

1.86

1.8

2.0

—

Polypectomy (DHB20)

2.65

1.86

2.9

1.9

—

Reactive arthropathies, FINNGEN

2.65

1.86

2.8

2.2

—

Gout, unspecified

107

1.87

1.85

2.5

2.1

—

Other/unspecified rheumatoid arthritis

2.39

1.85

1.3

1.7

—

IBD patients in KELA-register

129

1.78

1.85

1.7

1.9

—

Intracerebral haemorrhage

2.39

1.85

2.1

1.8

—

Cardiac arrest

3.64

1.84

2.2

1.1

—

Other shoulder lesions

2.21

1.84

2.9

1.8

—

Polyarthritis, unspecified

3.54

1.84

2.0

1.8

—

Benign neoplasm: Skin of trunk

3.54

1.84

2.7

1.6

—

Glaucoma suspect

221

1.58

1.83

1.4

1.9

—

Irritable bowel syndrome

167

1.68

1.83

1.7

1.6

—

Benign neoplasm: Pancreas

4.18

1.82

5.2

2.8

—

Vascular diseases of the intestine

4.17

1.82

1.0

2.3

—

Open wound of ankle and foot

2.12

1.81

1.7

1.9

—

Distal bite

4.14

1.81

2.6

1.5

—

Malignant neoplasm of breast, HER-negative

2.19

1.80

1.0

2.0

—

Hyperfunction of pituitary gland

3.05

1.80

1.6

1.7

—

Tobacco use

3.05

1.80

1.1

2.2

—

Acute suppurative otitis media

149

1.69

1.79

2.1

1.7

—

Genitourinary diseases

193

1.46

1.79

1.9

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

176

1.65

1.78

2.5

1.8

—

Retinal detachment with retinal break

2.17

1.77

1.9

—

Vasomotor and allergic rhinitis

218

1.57

1.77

2.6

1.8

—

Superficial injury of hip and thigh

2.09

1.75

1.5

1.9

—

Mental and behavioural disorders due to opioids

3.34

1.74

2.3

2.8

—

Total colectomy operation

3.34

1.74

3.2

2.9

—

Total colectomy

3.34

1.74

3.2

2.9

—

All dysplastic lesions of the vulva

3.34

1.74

1.8

1.6

—

Other and unspecified follicular disorders

3.34

1.74

1.3

2.8

—

Malignant neoplasm of bladder

3.33

1.74

3.3

1.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.90

1.74

2.6

1.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

539

0.71

1.74

1.6

2.0

—

Seronegative rheumatoid arthritis

2.22

1.73

1.3

2.1

—

Pruritus

2.22

1.73

2.6

1.6

—

Diseases of oral cavity, salivary glands and jaws

162

1.50

1.72

2.1

1.8

—

Calculus of lower urinary tract

2.92

1.72

1.1

1.9

—

Sequelae of other and unspecified infectious and parasitic diseases

2.92

1.72

1.3

2.7

—

Isolated proteinuria

3.86

1.71

1.0

1.7

—

Dilated cardiomyopathy

2.13

1.71

1.5

2.0

—

Disease of hard tissues of teeth, NOS

161

1.50

1.70

2.0

1.8

—

Other appendicitis

0.00

1.70

0.0

2.1

—

Inflammatory bowel disease, strict (require KELA)

133

1.73

1.69

1.7

1.9

—

Non-small cell lung cancer, including Hilmo

2.29

1.68

2.6

2.3

—

Urinary track infection

183

1.45

1.68

1.7

1.8

—

Operations 2 for CAVS

128

1.73

1.68

1.4

1.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

128

1.73

1.68

1.4

1.8

—

Ischaemic Stroke, excluding all haemorrhages

285

1.42

1.68

1.6

2.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

324

1.40

1.68

2.1

2.0

—

Calcific aortic valvular stenosis, including rheumatic fever

128

1.73

1.67

1.4

1.8

—

Fall on same level

115

480

1.28

1.67

1.9

2.0

—

Migraine

270

1.44

1.66

1.8

1.7

—

Other disorders of glucose regulation and pancreatic internal secretion

2.50

1.66

1.7

2.1

—

Faecal incontinence

2.50

1.66

3.6

1.3

—

Insulin, intermediate and long-acting

361

1.42

1.66

1.8

2.0

—

Type 1 diabetes, wide definition, subgroup 1

104

1.83

1.66

1.4

1.6

—

Vascular syndromes of brain in cerebrovascular disorders

3.16

1.66

1.2

2.2

—

Failed induction of labour

2.59

1.66

1.0

1.7

—

Pleural plaque

2.58

1.66

2.9

1.6

—

Glaucoma, exfoliation

2.58

1.65

1.1

1.7

—

Spinal stenosis

262

1.43

1.65

2.2

2.0

—

Acute lymphadenitis

2.80

1.65

1.6

2.4

—

Recurrent or chronic depression

212

1.47

1.64

2.7

1.9

—

Calcific aortic valvular stenosis, operated

129

1.72

1.64

1.4

1.8

—

Calcific aortic valvular stenosis

129

1.72

1.64

1.4

1.8

—

Nummular dermatitis

2.44

1.64

3.4

2.1

—

Migraine without aura

112

1.79

1.64

2.6

1.6

—

Status post-ami

1.81

1.62

1.5

1.3

—

Certain zoonotic bacterial diseases, including avohilmo

3.58

1.61

2.8

1.7

—

Non-small cell lung cancer, adenocarcinoma

3.58

1.61

1.6

2.2

—

Ocular pain

2.38

1.61

1.2

1.6

—

Tooth agenesis EXCLUDE clefts and syndromes

3.57

1.61

1.0

1.4

—

Acne vulgaris

2.38

1.61

2.7

2.1

—

Propionic acid derivatives

148

0.54

1.61

2.9

2.3

—

Other/unspecified dorsalgia

258

1.49

1.61

2.3

1.8

—

Benign neoplasm: Sigmoid colon

1.84

1.61

1.9

2.0

—

Superficial injury of abdomen, lower back and pelvis

1.87

1.60

1.4

1.9

—

Cardiomyopathy, other and unspecified

2.50

1.59

1.3

2.1

—

Other diseases of pancreas

2.33

1.58

1.9

1.6

—

Erosion of teeth , including avohilmo

159

1.64

1.58

2.2

1.7

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

3.01

1.58

1.8

2.9

—

UC patients in KELA-register (code 208), prior to 1994

3.01

1.58

1.5

2.0

—

Scar conditions and fibrosis of skin

3.01

1.58

2.2

1.3

—

Impetigo

3.00

1.58

1.5

2.5

—

Other or ill-defined heart diseases

3.00

1.58

1.2

2.5

—

Diseases of male genital organs

191

1.42

1.58

2.5

2.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

251

1.49

1.57

1.5

1.8

—

Benign neoplasm: Caecum

2.20

1.56

2.3

1.7

—

Acute appendicitis, with complications

114

1.76

1.56

1.6

2.0

—

Chondropathies

1.85

1.55

2.1

1.8

—

Polymyalgia rheumatica

2.27

1.55

1.5

1.6

—

Macular cyst

3.34

1.52

1.2

1.8

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.34

1.52

1.0

1.3

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

3.34

1.52

1.8

2.5

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS